Mosunetuzumab Biosimilar - Research Grade,ichor.bio,ICH5026
Detects human CD3/CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Mosunetuzumab.
Host
CHO cells
Reactivity
Human
Platform ID
BAB075106903
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameMosunetuzumab Biosimilar - Research Grade
Cat. No.ICH5026
Accession NumberP07766
HostCHO cells
IsotypeHuman IgG1
ReactivityHuman
Concentration5mg/ml
TargetCD3e + CD20
Purity>90% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only
Scientific Background
ichorbioï؟½s Mosunetuzumab biosimilar is a bispecific, humanized monoclonal antibody with potential antineoplastic activity. Anti-CD20/CD3 bispecific monoclonal antibody BTCT4465A contains two antigen-recognition sites: one for human CD3, a T-cell surface
Synonyms
BTCT4465A
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.